NOTCH1 mutant clones occupy the majority of normal human esophagus by middle age but are comparatively rare in esophageal cancers, suggesting NOTCH1 mutations drive clonal expansion but impede carcinogenesis. Here we test this hypothesis. Sequencing NOTCH1 mutant clones in aging human esophagus reveals frequent biallelic mutations that block NOTCH1 signaling. In mouse esophagus, heterozygous Notch1 mutation confers a competitive advantage over wild-type cells, an effect enhanced by loss of the second allele. Widespread Notch1 loss alters transcription but has minimal effects on the epithelial structure and cell dynamics. In a carcinogenesis model, Notch1 mutations were less prevalent in tumors than normal epithelium. Deletion of Notch1 reduced tumor growth, an effect recapitulated by anti-NOTCH1 antibody treatment. Notch1 null tumors showed reduced proliferation. We conclude that Notch1 mutations in normal epithelium are beneficial as wild-type Notch1 favors tumor expansion. NOTCH1 blockade may have therapeutic potential in preventing esophageal squamous cancer.
Aging tissues accumulate somatic mutations1,2,3,4. Some mutations confer a competitive advantage on progenitor cells, which may form mutant clones that colonize normal tissue. These clonal expansions are often associated with mutations linked to cancer and may represent the first step in malignant transformation4. However, the under-representation of NOTCH1 mutants in esophageal cancer compared with normal aging epithelium suggests NOTCH1 mutations may inhibit malignant transformation2,5.
NOTCH1 is a cell surface receptor composed of an extracellular domain (NEC) and a transmembrane and cytoplasmic subunit (NTM), interacting noncovalently through the negative regulatory region (NRR; Extended data Fig. 1a)6,7. The NRR comprises three Lin12-Notch repeats (LNR) and a heterodimerization domain (HD) that inhibits NOTCH1 activation in the absence of ligand8. Ligands bind to conserved epidermal growth factor (EGF) repeats in the NEC. This results in proteolytic cleavage events releasing the intracellular domain (NICD), which translocates to the nucleus and alters target gene transcription8. In the esophagus, NOTCH1 protein is expressed in proliferating cells and regulates both development and adult tissue maintenance (Extended data Fig. 1a,b)9.
Different studies have suggested that NOTCH1 is a tumor suppressor or conversely may promote esophageal carcinogenesis10,11,12. Here we investigate how NOTCH1 mutants colonize the epithelium, their impact on tissue maintenance and their effect on esophageal carcinogenesis2,4.
NOTCH1 mutant clones in human esophagus
Deep targeted sequencing studies have revealed numerous NOTCH1 mutants in human esophagus but have not visualized clones and resolved which NOTCH1 mutation(s) or copy number alterations they carry2,4. To achieve this, histological sections of normal epithelium from elderly donors were immunostained for NOTCH1 (Fig. 1a). Positive and negative staining areas were microdissected and targeted sequencing for 322 genes associated with cancer was performed (Fig. 1b). A total of 247 protein-altering somatic variants were identified across 86 samples from six donors aged 43–78. The predominant mutant genes were NOTCH1, TP53 and NOTCH2 (refs. 2,4; Supplementary Tables 1–3 and Supplementary Note). Near clonal NOTCH1 mutations with an average variant allele frequency (VAF) of 0.36 were detected in 81% (70/86) of samples (Fig. 1c,d). Ninety-three percent (25/27) of negative staining areas carried nonsense, essential splice mutations or indels in NOTCH1 with copy neutral loss of heterozygosity (CNLOH) of the NOTCH1 locus (human GRCh37—chr9:139,388,896–139,440,238) or a further mutation, likely to disrupt the second NOTCH1 allele (Fig. 1d,e). Fifty-nine percent (35/59) of positively stained samples carried a missense NOTCH1 mutation and most of these had either CNLOH or a second mutation (Fig. 1d–f, Extended data Fig. 1c,d and Supplementary Table 4). Overall, most samples (73%, 51/70) had likely biallelic NOTCH1 alterations (Fig. 1f). To test if the mutations disrupted NOTCH1 function, we stained consecutive sections from additional donors for NOTCH1 protein and NICD1, which is detectable in the nucleus during active signaling (Fig. 1g,h, Extended data Fig. 1a and Supplementary Table 5)13. The proportion of epithelium with active NOTCH1 decreased with age (Kendall’s tau-b = −0.67, P = 0.014). In older donors, in whom NOTCH1 mutations are common, NOTCH1− areas were associated with NICD1 loss. We also found occasional NOTCH1+ NICD1− areas, consistent with the presence of missense mutant proteins that reach the cell membrane but lack signaling activity (Fig. 1g,h). NICD1+ and NICD1− areas were histologically undistinguishable, with no significant differences in tissue thickness, cell density or the expression of the proliferation marker Ki67 (Extended data Fig. 1e–h). We conclude that many NOTCH1 mutant clones in aging human esophagus carry biallelic alterations that disrupt signaling.
Notch1 mutations increase clonal fitness
To investigate how NOTCH1 mutant clones colonize normal epithelium, we tracked the fate of Notch1 mutant clones in transgenic mice using lineage tracing. Mouse esophageal epithelium consists of layers of keratinocytes. Proliferation is restricted to progenitor cells in the basal layer (Extended data Fig. 2a). Differentiating cells cease dividing, leave the basal layer and migrate toward the epithelial surface where they are shed. Progenitor division is linked to the exit of a nearby differentiating cell from the basal layer, ensuring basal cell density is kept constant14. Dividing progenitors generate either two progenitor daughters, two differentiating daughters or one cell of each type. In wild-type tissue, the probabilities of each progenitor outcome are balanced, generating equal proportions of progenitor and differentiated cells, maintaining cellular homeostasis (Extended data Fig. 2a)15,16. Mutations that alter progenitor fate leading to excessive production of progenitors drive mutant clone growth17,18.
For lineage tracing, we generated AhCreERT Rosa26floxedYFP Notch1flox triple transgenic (YFPCreNotch1) mice. These animals carry a conditional Notch1 allele and a genetic labeling system. An inducible Cre recombinase (AhCreERT) was used to delete one or both conditional Notch1 alleles in Notch1wt/flox or Notch1flox/flox animals and induce a separate conditional yellow fluorescent protein (YFP) reporter allele (Rosa26floxedYFP)15,19. YFP was expressed in recombined epithelial cells and their progeny (Extended data Fig. 2b,c). This model was induced at low dose to recombine scattered single basal cells (clonal induction) or at a higher level to recombine a large proportion of basal cells (high induction) (Extended data Fig. 2c,d).
Excision of the Notch1 allele and expression of the YFP reporter at the Rosa26 locus can occur in combination or separately, resulting in Notch1 mutant or wild-type cells expressing YFP or not (Extended data Fig. 2c,d). We confirmed the recombination status of exon 1 of Notch1 of wild type and fully recombined Notch1+/− and Notch1−/− esophageal epithelium. Notch1 mRNA and protein expression was halved in Notch1+/− and abolished in Notch1−/− cells compared with wild-type keratinocytes (Extended data Fig. 3a–h and Supplementary Table 6). We then performed genetic lineage tracing by inducing recombination in scattered single progenitors in YFPCreNotch1+/+, YFPCreNotch1+/flox or YFPCreNotch1flox/flox mice. YFP-expressing clones were detected by imaging sheets of epithelium stained for YFP and NOTCH1 (Fig. 2a). YFP+ Notch1+/− or YFP+ Notch1−/− clones were identified from reduced intensity or absence of NOTCH1 immunostaining, respectively, a method validated by detecting Notch1 recombination in microdissected clones (Fig. 2b, Extended data Fig. 3i–n and Supplementary Note).
The number and location of cells in YFP-expressing clones of each genotype were determined by 3D confocal imaging. The size of YFP+ Notch1+/− clones was substantially increased compared to wild-type YFP+ Notch1+/+ clones at all time points. YFP+ Notch1−/− clones were larger still (Fig. 2b–d, Extended data Fig. 3i,j and Supplementary Table 7). To examine the cellular mechanisms underlying mutant clonal expansion, we used short-term cell tracking by labeling cycling cells with the S phase probe 5-ethynyl-2′-deoxyuridine (EdU).
We first counted the proportion of basal cells positive for EdU at 1 h after labeling, which measures the fraction of cells in S phase (Fig. 2e,f). This value was similar for cells within Notch1+/− clones and wild-type cells distant from clones (Fig. 2g and Supplementary Table 8). Within Notch1−/− mutant clones, the proportion of EdU+ basal cells was marginally lower than in wild-type cells (Fig. 2h). We conclude neither Notch1+/− nor Notch1−/− clonal expansion results from an increase in mutant cell division rate compared with wild-type cells.
A 48 h EdU experiment labeled S phase cells and tracked the fate of the two cells generated by the subsequent mitosis over the following 48 h. The pair of labeled cells may remain in the basal layer, or one or both may differentiate and exit the basal layer (Fig. 2i,j). The ratio of EdU-labeled suprabasal cells to the total EdU-labeled cells reflects the rate of production of differentiating cells in the basal layer and their stratification into the suprabasal layers. In Notch1+/− and Notch1−/− clones, this ratio is decreased, consistent with a tilt in mutant progenitor cell fate, so that more progenitors and fewer differentiating daughters are produced per average cell division (Fig. 2k). Strikingly, adjacent to Notch1−/− clones, there was an increase in the suprabasal EdU+:total EdU+ cell ratio in the wild-type cells at the clone margin compared with wild-type cells further from the mutant clone (Fig. 2j,l). This, along with a small decrease in the proportion of wild-type S phase cells at the clone edge, indicates that wild-type cells adjacent to the clone exit the cell cycle, differentiate and exit the basal layer at an increased rate, a phenomenon also reported in previous studies of Notch inhibited keratinocytes interacting with wild type cells (Fig. 2h)18,20.
These observations explain the increased fitness of Notch1−/− over Notch1+/− clones. Cell density was similar in both mutant genotypes and wild-type areas, suggesting that the linkage between cell division and the exit of a nearby differentiating cell from the basal layer is maintained (Fig. 2m,n). Within this constraint, the driving of wild-type cell differentiation and stratification permits Notch1−/− cell division at the clone edge, accelerating clonal expansion (Fig. 2o).
These observations were integrated into a Wright–Fisher style quantitative model in which fit mutant clones expand until they collide with other mutant clones of similar fitness, at which point they revert to neutral competition21. We fitted this model to the clone size data. The inferred fitness for Notch1+/− clones was higher than that of wild-type cells and the inferred fitness of Notch1−/− clones markedly greater than that of heterozygous clones (Extended data Fig. 4a–d, Video 1 and Supplementary Note).
Notch1 haploinsufficiency enables epithelial colonization
Clones generated by the transgenic deletion of Notch1 alleles may not reflect the behavior of Notch1 mutants that appear during aging. We therefore investigated spontaneous Notch1 mutant clones in control YFPCreNotch1+/+ mice, and the heterozygous epithelium of highly induced YFPCreNotch1+/flox animals. Both strains were aged before immunostaining the epithelium for NOTCH1 (Fig. 3a). The area of epithelium stained negative for NOTCH1 increased progressively to 12% of Notch1+/+ and 78% of Notch1+/− epithelium by 65 weeks (Fig. 3b,c and Supplementary Table 9). Widespread loss of NICD1 staining was seen in aged Notch1+/− tissue (Extended data Fig. 5a,b). These observations suggest that, as in humans, Notch1 mutants colonize the aging mouse esophagus and that selection is enhanced in Notch1+/− epithelium.
To localize potential clones, we stained for NOTCH1 and the YFP reporter. Aging Notch1+/− epithelium contained multiple ovoid areas of homogenous NOTCH1 staining, positive or negative for YFP but far larger than most YFP labeled clones (Fig. 3d,e). These were suggestive of clonal expansion. A total of 246 such ‘expanded’ areas along with typical ‘nonexpanded’ regions were dissected and underwent targeted sequencing for 73 Notch pathway and cancer-related genes (Supplementary Tables 1, 10 and 11). We analyzed for CNLOH and mutations with VAF ≥ 0.2, as below this threshold mutations were considered unlikely to drive clonal expansion. Nintey-seven percent (180/185) of the ‘expanded’ areas had either Notch1 protein-altering mutations with VAF ≥ 0.2 or CNLOH involving the Notch1 locus (GRCm38—chr2:26,457,903-26,503,822). In contrast, only 2 of 61 nonexpanded areas carried Notch1 mutations and none had Notch1 CNLOH (Fig. 3f, Extended data Fig. 5c,d and Supplementary Table 10). Only a few mutations in other genes were found, some may have been passengers within a Notch1 mutant clone. Ninety-four percent (169/180) of expanded areas with Notch1 altering events carried only a single event (about 50% one Notch1 protein-altering mutation and the remainder CNLOH) with an average VAF 0.44, consistent with them being clones carrying spontaneous changes affecting the nonrecombined Notch1 allele (Fig. 3e–g, Supplementary Tables 10, 11 and Extended data Fig. 5c,d). Among clones carrying a Notch1 mutation, 85% of those stained positive for NOTCH1+ harbored missense mutations while NOTCH1 negatively stained clones carried mainly indel/splicing (51%) or nonsense mutations (46%) (Fig. 3g). Overall, these results were consistent with findings in aging human esophagus (Fig. 1).
To test the impact of missense Notch1 mutations, we used an ex vivo functional assay (Extended data Fig. 5e–j and Supplementary Table 10)22. Notch1+/− tissues in Fig. 3e–g were incubated with ethylenediaminetetraacetic acid (EDTA) at 37 °C before fixation. This promotes NOTCH1 cleavage and nuclear migration of NICD without ligand binding (Extended data Fig. 1a)22. Some NOTCH1+ clones displayed nuclear staining, but others did not (Extended data Fig. 5e). Nuclear staining clones were enriched in missense mutations in the ligand binding site, EGF repeats 8–12, whereas non-nuclear staining clones were enriched mutations in the LNR repeats of the NRR domain (Extended data Fig. 5g,h, P = 0.001, Chi-square test). Most of ligand binding domain mutations had highly destabilizing properties, consistent with disrupting ligand binding, a process bypassed in the EDTA assay (Extended data Fig. 5i)23,24. The NRR domain mutants were clustered in the LNR1 and LNR2 domains (Extended data Fig. 5j)25. In contrast, NOTCH1 activating mutations in human T cell acute lymphoblastic leukemia (T-ALL) (https://cancer.sanger.ac.uk/cosmic) cluster in the HD domain of the NRR and promote NEC cleavage without ligand interaction (two-sided Fisher exact test comparing mutation counts in the LNR1-2 and LNR3-HD subregions of the NRR, P = 1.48 × 10−10, Extended data Fig. 5j)26,27. These observations suggest that esophageal NRR domain mutations may prevent the cleavage of NOTCH1. We conclude that in heterozygous epithelium, most spontaneous mutants disrupt NOTCH1 function, conferring a fitness advantage over neighboring cells.
Collectively these observations reveal that haploinsufficiency is key for the normal esophagus to be colonized so effectively by Notch1 mutants. Neutral mutants do not colonize the tissue15,28. Loss of one allele biases mutant progenitor cell fate toward the production of progenitors, increasing the likelihood that mutant clones will expand and persist in the epithelium (Extended data Fig. 4e,f and Video 2). Notch1 inactivated cells have a further increased fitness so that subclonal loss of the second allele within a persisting heterozygous clone will generate cells that outcompete both Notch1+/+ and Notch1+/− neighbors (Fig. 3h). This model explains the high prevalence of clones with NOTCH1 mutation and CNLOH in aging human esophagus.
Notch1 −/− epithelium has minimal phenotype
Epithelium lacking functional NOTCH1 might be expected to have a cellular phenotype. To explore the effects of Notch1 loss in the mouse esophagus, we first performed bulk RNA sequencing (RNA-seq) on peeled epithelium from wild type, and highly induced, fully colonized Notch1+/− and Notch1−/− esophagus (Extended data Fig. 3f–h and Extended data Fig. 6a–e). In comparison with wild-type tissue, 20 genes in Notch1+/− and 227 genes in Notch1−/− esophagus were differentially expressed (P adjusted <0.05, Extended data Fig. 6b–d and Supplementary Tables 12,13). These included the Notch1-regulated genes Igfbp3 and Sox9 (Supplementary Table 14)18,29,30. Gene set enrichment analysis (GSEA) showed that transcripts of genes involved in DNA replication were downregulated in Notch1−/− colonized epithelium (Extended data Fig. 6e and Supplementary Table 15).
To phenotype fully colonized Notch1−/− epithelium, we performed single-cell RNA-seq (scRNA-seq) on highly induced YFPCreNotch1flox/flox and uninduced control mouse esophagus (Fig. 4a–i, Extended data 7a–k and Supplementary Table 16). After filtering out poor-quality cells, a total of 13,111 cells remained for analysis, from two biological replicates per genotype (Fig. 4b and Supplementary Note). The proportions of keratinocytes, fibroblasts, immune and endothelial cells were similar in both genotypes, confirmed by staining esophageal sections (Fig. 4c and Extended data Fig. 7b–d)31. Keratinocytes showed no significant difference in density in Uniform Manifold Approximation and Projection (UMAP) space between the two genotypes (Fig.4d and Supplementary Note). The analysis revealed a continuum of keratinocyte cell states, from progenitors expressing Krt14 to differentiating cells expressing Krt4 or Tgm3 to cornified cells expressing Lor (Extended data Fig. 7h–k). We used these markers to discriminate basal and suprabasal cells in UMAP space, finding similar proportions of both populations in control and Notch1−/− epithelium (Fig. 4e and Supplementary Note). In a further analysis, we assigned keratinocytes to cycling basal, resting basal or differentiating cells, finding no substantial differences between genotypes32 (Fig. 4f–i and Supplementary Note).
To validate the scRNA-seq findings, we performed a cell-tracking assay. Mice with Notch1−/− esophageal epithelium and littermate controls were injected EdU and 5-bromo-2′-deoxyuridine (BrdU) at 48 h and 1 h, respectively, before collection (Extended data Fig. 7l). Staining for EdU revealed the fate of S phase cells over the following 48 h, BrdU+ cells were currently in S phase. Cells were also stained for phospho-Histone H3 (pHH3), a G2/M phase marker (Extended data Fig. 7m). The ratio of suprabasal EdU+:total EdU+ cells reflecting the generation of differentiating cells and their stratification, the proportion of BrdU+ basal cells and the percentage of pHH3+, BrdU− basal cells were all similar in wild type and Notch1−/− epithelium, consistent with the scRNA-seq findings (Extended data Fig. 7n–r, Supplementary Table 17 and Supplementary Note).
We also examined the epithelium in induced YFPCreNotch1flox/flox mice and control littermates that were aged 52 weeks. Tissue thickness, basal cell density and expression of the differentiation markers KRT14, KRT4 and LOR and the proliferation marker Ki67 were similar in both genotypes, (Fig.5a–d and Supplementary Table 18). Pulse labeling and short-term lineage tracing for 48 h with EdU confirmed no significant difference in the proportion of S phase cells or in the stratification of differentiating cells, respectively, between Notch1−/− and wild-type esophagus (Fig. 5e–h).
We conclude that once Notch1−/− cells have occupied the epithelium, their behavior reverts toward that of wild-type cells so that tissue integrity is maintained.
Notch1 loss slows tumor growth
Next, we explored the role of Notch1 in esophageal carcinogenesis. We began by treating YFPCreNotch1 wild-type mice with the mutagen diethylnitrosamine (DEN), and sorafenib (SOR), a protocol that generates high-grade dysplastic lesions33. Tissue was collected after aging 28 weeks (Fig. 6a). Deep targeted sequencing of 73 cancer-associated and Notch pathway genes was performed on macroscopic tumors and a gridded array of normal epithelium (Fig. 6a and Supplementary Tables 19–22).
The normal epithelium contained a high density of clones carrying protein-altering mutations. To determine which genes conferred a clonal advantage, we calculated the ratio of silent to protein-altering mutations in each gene, dN/dS3,34. Mutant genes under positive selection with a dN/dS ratio substantially above 1 (q < 0.05) were the Notch pathway genes Notch1, Notch2 and Adam10, plus Fat1, Trp53 and Arid1a, all of which are selected in normal human esophagus along with Ripk4 and Chuk (Supplementary Table 21)2,21.
In tumors, the most prevalent mutant gene was the known mouse esophageal tumor driver Atp2a2, which is not selected in normal epithelium (Extended data Fig. 8a,b and Supplementary Tables 19–22)35,36. Protein-altering Notch1 mutations were under weaker selection and less prevalent in tumors than in the adjacent epithelium (Fig. 6b,c, Extended data Fig. 8a,b and Supplementary Tables 19–22). Immunostaining confirmed more cells stained positive for NOTCH1 and NICD1 in tumors than in normal tissue (Fig. 6d–g and Supplementary Table 23). These findings parallel observations in humans and indicate Notch1 wild-type cells are more likely to contribute to tumors than those carrying Notch1 mutations2,5.
Next, we used a high induction protocol to delete one or both alleles in the entire esophageal epithelium of YFPCreNotch1flox/flox and YFPCreNotch1+/flox mice before DEN and SOR treatment. Uninduced littermates were used as controls (Fig. 7a). The density of tumors was similar in all three genotypes, arguing Notch1 is not required for tumor initiation (Fig. 7b,c and Supplementary Table 24). However, tumors were significantly smaller in Notch1−/− epithelium, in which immunostaining confirmed the loss of Notch1 expression and function (Fig. 7d–f and Supplementary Table 24). Immunostaining for markers of differentiation (LOR, ITGA6 and KRT14) showed multiple layers of undifferentiated keratinocytes in lesions of both genotypes. Markers of apoptosis (cleaved caspase 3), endothelial cells (CD31) and immune cells (CD45) were also similar in tumors from Notch1−/− and Notch1+/+ epithelium (Fig. 7e,f and Extended data Fig. 8d,e). CDH1 loss contributes to tumorigenesis37. Tumors from Notch1+/+, but not Notch1−/−, esophagus displayed focal loss of CDH1 expression (Extended data Fig. 8f–h and Supplementary Table 24).
These observations argue that Notch1 favors tumor growth. To test this hypothesis, we treated wild-type mice with a NOTCH1 function blocking antibody (anti-NRR1.1E3)38. The antibody reduced levels of cleaved NOTCH1 in esophageal epithelium, abolished nuclear NICD1 immunostaining and altered levels of multiple transcripts encoding Notch1 loss of function markers (Extended data Fig. 9a–e, Extended data Fig. 6d and Supplementary Table 25). Anti-NRR1.1E3 also reduced the expansion of Notch1−/− clones in clonally induced YFPCreNotch1flox/flox mice by inhibiting NOTCH1 signaling in wild type cells (Extended data Fig. 9f–i and Supplementary Table 25). Wild-type mice were given DEN and SOR, tumors allowed to develop for 9 weeks and anti-NRR1.1E3 or control antibody given for 6 weeks (Fig. 7g). Anti-NRR1.1E3 significantly reduced tumor size compared with control, indicating NOTCH1 signaling favors the growth of established lesions (Fig. 7h, i and Supplementary Table 24).
To understand how Notch1 loss alters tumor growth, we sequenced tumors from Notch1−/− epithelium, finding they share the same driver mutation, Atp2a2, (6/7 tumors), as the tumors from Notch1+/+ epithelium (17/17 tumors) (Extended data Fig. 8a–c and Supplementary Tables 20 and 26)35,36. Comparison of transcriptomes of tumors and adjacent normal tissue showed an upregulation of transcripts encoding genes linked with DNA replication, cell cycle and RNA processing and downregulation of mRNAs associated with lipid metabolism in tumors of both genotypes (Fig. 8a–c, Extended Data Fig. 10a,b and Supplementary Tables 27 and 28). These changes are consistent with the reported effects of Atp2a2 mutation on keratinocytes35,36,39,40. Comparison of tumors from Notch1+/+ and Notch1−/− epithelium revealed DNA replication and cell-cycle-associated transcripts were significantly downregulated in Notch1−/− tumors (Fig. 8d–f, Extended data Fig. 10c,d and Supplementary Tables 29 and 30). Furthermore, the proportion of cycling cells expressing pHH3 and CCNB1 within KRT14+ cells was reduced in tumors from Notch1−/− compared to Notch1+/+ esophagus (Fig. 8g,h, Extended data Fig. 10e,f and Supplementary Table 24). Finally, as RAS/MEK/ERK signaling is activated in Atp2a2 mutant cells, we measured phospho-ERK1/ERK2 and total ERK1/ERK2 staining finding a significant decrease of the former in tumors from Notch1−/− compared to Notch1+/+ epithelium (Fig. 8i,j and Supplementary Table 24)36,40. These findings are consistent with attenuated signaling downstream of mutant Atp2a2 in tumor cells lacking Notch1 (Fig. 8k).
These results shed light on the disparity in the prevalence of NOTCH1 mutations in normal esophageal epithelium and tumors2,5. Mutations reducing the function of one Notch1 allele confer a competitive advantage on mutant progenitors, making it likely they will form persistent, expanding clones. As the heterozygous mutant population grows, the probability that the remaining allele will be lost increases. When this happens, it confers a further increase in fitness (Fig. 3h). By driving wild-type cell differentiation, Notch1 null cells at the clone margins can divide, resulting in extensive colonization of the epithelium (Fig. 2o). This mechanism explains how clones with biallelic NOTCH1 disruption dominate normal human esophagus. Such ‘supercompetition’ also occurs in the intestine where Apc mutant intestinal stem cells drive the differentiation of their wild-type neighbors to colonize the intestinal crypt41.
Once an area has been colonized by biallelic Notch1 mutants, the phenotype of mutant cells reverts toward that of wild-type cells. This reversion toward a near-normal cell state explains the normal appearance of aged human esophageal epithelium despite NOTCH1 signaling being disrupted in most of the tissue.
In Atp2a2 mutant tumors, the constraint that links cell division to the exit of differentiating cells from the basal cell layer to maintain cellular homeostasis does not operate. In this context, the faster cells divide, the faster the lesion will expand. As loss of Notch1 slows the cell division rate, Notch1−/− lesions are smaller than wild-type tumors (Fig. 8k).
Might these findings be relevant to humans? Over 90% of human esophageal squamous cell carcinoma (ESCC) retain one or more wild-type copies of NOTCH1 but develop from epithelium where a high proportion of cells have biallelic NOTCH1 disruption, arguing wild-type NOTCH1 favors ESCC development. What of the subset of ESCC that does have biallelic NOTCH1 disruption?5 One possibility is that NOTCH1 loss, in association with multiple other genomic alterations, promotes transformation in these cases. Alternatively, it is plausible that the NOTCH1 alterations in these tumors are ‘passengers’, carried over from normal tissue with the requirement for wild-type NOTCH1 in carcinogenesis bypassed by other genome changes.
Notch1 illustrates how inactivating mutations in the same gene can drive clonal expansion in normal tissue but impair tumor growth. This is due to the differences in cell dynamics between wild-type normal tissue and a mutated tumor. Our results highlight the potential of NOTCH1 blockade in reducing the growth of premalignant tumors. NOTCH1 inhibitors are in clinical development, and investigation of their potential in esophageal neoplasia seems warranted.
The study protocol was ethically reviewed and approved by the UK National Research Ethics Service Committee East of England—Cambridge South, Research Ethics Committee under protocol reference 15/EE/0152 NRES.
Esophageal tissue was obtained from deceased organ donors. Written Informed consent was obtained from the donor’s relatives. A sample of mid-esophagus was removed, placed in University of Wisconsin (UW) organ preservation solution (Belzer UW Cold Storage Solution, Bridge to Life) and flash frozen in tissue freezing medium (Leica, 14020108926)2.
Triplet 10 μm serial cryosections fixed with 4% paraformaldehyde for 10 min were stained for NOTCH1/KRT4/ITGA6/DNA (section 1), NICD1/KRT14/DNA (section 2), and NOTCH1/KRT14/ITGA6/DNA (section 3) and imaged (see Histology and Confocal microscopy sections). Corresponding areas in each section were identified. Contiguous regions staining positive or negative for NOTCH1 or nuclear NICD1 were identified and their length was measured using Volocity 6 software (Perkin Elmer). For morphological analysis of NICD1+ and NICD1− areas, sections were stained for NICD1/KRT14/DNA or NICD1/Ki67/DNA. Epithelial thickness, cell counting and density measurement were performed using Volocity 6 software (Perkin Elmer).
Sampling, library preparation, targeted sequencing processing and analysis are detailed in Supplementary Note.
All experiments were ethically reviewed under and conducted in accordance with the UK Home Office Project Licenses 70/7543, P14FED054 and PF4639B40. Both male and female adult mice of 10–16 weeks of age at the start of the experiments were used. Animals were housed in individually ventilated cages and fed on standard chow. Mice were maintained at SPOF health status. B6.129 × 1-Notch1tm2Rko/GridJ mice were purchased from the Jackson Laboratory and crossed with Rosa26floxedYFP and AhCreERT to generate YFPCreNotch1 triple mutant mice (Extended data Fig. 2b–d)15,19,42. C57BL/6J wild-type mice were also used as indicated.
qPCR recombination assay
Design of the assay
Specific primer sets were designed to analyze excision of the floxed exon 1 of Notch1 by Cre recombinase (Extended data Fig. 3c). Primer set A allows intragenic normalization using the nonfloxed Notch1 exon 3; primer set B measures the disappearance floxed exon 1 with recombination; primer set C specifically detects exon 1 recombination (primer sequences are provided in Supplementary Table 32). Quantitative PCR on genomic DNA was carried out using specific primers and SYBR Green master mix (Thermo Fisher Scientific, 4309155) according to the manufacturer’s instructions in a StepOnePlus Real-Time PCR System (Thermo Fisher Scientific, 4376600). Relative qPCR expression was calculated using delta–delta Ct method, a wild type or Notch1−/− reference sample was used within the same assay for set B or set C, respectively. Validation of the linearity of the recombination assay was performed against a standard curve reproducing different recombination rates with Exon 1/Exon 3 ratios of 1, 0.75, 0.5, 0.25 and 0. The standard curve was made using diluted genomic DNA from the esophagus of highly induced and fully recombined Notch1−/− mice (as verified by qPCR, staining and protein assay) and from Notch1 wild-type tissue.
Recombination status in highly induced tissues
Genomic DNA was extracted from large pieces of freshly peeled epithelium using either AllPrep DNA/RNA mini kit (Qiagen) or QIAamp DNA micro kit (Qiagen, 56304) and qPCR assay was performed using set B. Full recombination of the esophageal epithelium will reduce the Exon 1/Exon 3 ratio to zero in induced Notch1−/− mice and halve it in induced Notch1+/− mice compared to wild-type mice.
Detection of the recombined allele in microdissected fixed tissue
Clonally induced tissues were fixed and stained for NOTCH1 and YFP at 4 weeks postinduction for YFPCreNotch1flox/flox mice and 13 weeks postinduction for YFPCreNotch1+/flox mice. NOTCH1 detection and intensity measurement were used to resolve Notch1−/− and Notch1+/− clones, respectively (Supplementary Note). Putative clonal and control areas were then microdissected from the esophageal epithelium. Clonal microdissection was carried out under a Fluorescent Stereo Microscope Leica M165 FC (Leica) using 0.25 mm diameter punch (Stoelting, 57391) as shown in Extended data Fig. 3k–n. gDNA from the microbiopsies was extracted using Arcturus PicoPure DNA extraction kit (Applied Biosystems, 11815-00) following the manufacturer’s instructions. gDNA extracted from fixed tissue is fragmented, altering the linearity of the qPCR assay. Therefore, set C rather than Set B was used to determine the recombination status of the microbiopsies as specific detection of the recombined allele above background noise was sufficient to conclude on a reliable discrimination of mutant clones. Nonetheless, on average recombined exon 1 detection increased two folds in Notch1−/− clones compared to Notch1+/− clones.
RNA extractions were performed on peeled mouse esophageal epithelium as described in the RNA-seq method section (Supplementary Note). Total RNA was measured using Qubit RNA BR Assay Kit (Thermo Fisher Scientific, Q10211). cDNA synthesis of 500 ng total RNA was performed using QuantiTect Reverse Transcription Kit (Qiagen, 205313). RT-qPCR was performed with Taqman Fast Advanced Master Mix (Thermo Fisher Scientific, 4444557) on StepOnePlus Real-Time PCR System (Thermo Fisher Scientific, 4376600) and analyzed using StepOne Software v2.3. Relative qPCR expression to Gapdh housekeeping gene was calculated using delta–delta Ct method. The Taqman assays used for quantification are shown in Supplementary Table 32.
Immune capillary electrophoresis
RLT Plus lysates with Complete Protease Inhibitor (Roche, 11836170001) homogenized as described in the ‘RNA-seq’ section (Supplementary Note) were passed through the RNA binding column from the AllPrep DNA/RNA Mini kit (Qiagen) and the flow through was collected for protein precipitation. For precipitation, nine volumes of ice-cold pure Ethanol were mixed with the lysates before storage overnight at −80 °C. Precipitates were spun for 30 min at 20,000g at 4 °C, pellets were dried and solubilized progressively with 5% Sodium dodecyl sulfate in 100 mM TEAB solution (Sigma-Aldrich, T7408). Total protein quantification was performed using Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, 10678484). Immune capillary electrophoresis was performed using Wes Simple (ProteinSimple) following manufacturer’s instructions and analyzed using Compass for SW version 4.1.0. Primary antibodies were the following: anti-NOTCH1 targeting C terminus of the protein (Cell signaling, 3608); anti-NOTCH2 targeting C terminus of the protein (Cell signaling, 5732); anti-α-Tubulin (Cell signaling, 2125).
Whole-mount preparation of mouse esophagus
Mouse esophagus was opened longitudinally and the muscle layer was removed with forceps. For lineage tracing and EdU/BrdU experiments, tissue was incubated for 15 min in Dispase I (Roche, 04942086001), diluted at 1 mg ml−1 in PBS before separating the epithelium with fine forceps. For all other immunostaining experiments (including long-term antibody treatment), tissue was incubated for 2 h 15 min to 3 h in 5 mM EDTA at 37 °C before peeling the epithelium. The epithelium was then flattened and fixed in 4% paraformaldehyde for 1 h 15 min at room temperature under agitation, washed in PBS and stored in PBS at 4 °C21.
Whole-mount tissues were stained as previously described43. Tissues were incubated for 1 h in staining buffer (0.5% BSA, 0.25% fish skin gelatin, 0.5% Triton X-100 and 10% donkey serum in PHEM). This blockage step was followed by incubation with primary antibodies (Supplementary Table 31) in staining buffer overnight at room temperature, three washes of 30 min with 0.2% Tween-20 in PHEM and incubation with secondary antibodies (Supplementary Table 31) in staining buffer for 3 h at room temperature. After further washes, tissues were incubated for an hour at room temperature with 1 μg ml−1 DAPI or 0.5 μM Sytox Blue solution (Biolegend, 425305) to stain cell nuclei and mounted using Vectashield mounting media (Vector Laboratories, H-1000).
Hematoxylin and eosin staining (H&E)
H&E was either performed on 10 µm cryosectioned tissue processed as described below or on 5 µm paraffin-embedded tissue sections. Before paraffin embedding, esophageal tissue was collected and fixed in 4% paraformaldehyde for at least 2 h before undergoing progressive dehydration in Tissue-Tek VIP 6 AI tissue processor (Sakura). Slides were then scanned at objective ×20 using NanoZoomer S60 Digital slide scanner (Hamamatsu).
Immunostaining on esophageal sections
Esophageal tissue was flash frozen in tissue freezing medium (Leica, 14020108926). Ten micrometer transverse sections were fixed with 4% paraformaldehyde for 10 min, blocked in staining buffer (0.5% BSA, 0.25% fish skin gelatin, 0.5% Triton X-100 and 10% donkey serum in PHEM) and stained with primary and secondary antibodies for 3 h to overnight at room temperature (Supplementary Table 31). PHEM washes were performed between incubations. Before NICD1 staining, sections were incubated 20 min in 50 mM Glycine/PBS solution. Finally, tissues were incubated for an hour at room temperature with 1 μg ml−1 DAPI or 0.5 μM Sytox Blue solution (Biolegend, 425305) to stain cell nuclei and mounted in Vectashield mounting media (Vector Laboratories, H-1000). For Extended data Fig. 3b, freshly collected esophagus was fixed in 4% PFA for 2 h and embedded in 4% low-melting agarose. Hundred micrometer thick Vibratome (Leica) sections were cut permeabilized for 1 h and stained as for whole mounts.
Immunofluorescence images were acquired on a Leica TCS SP8 confocal microscope using ×10, ×20 or ×40 objectives. Typical settings for acquisition were optimal pinhole, line average 3 and 4, and scan speed 400–600 Hz and a resolution of 1024 × 1024 pixels. Visualization and image analysis were performed using Volocity 6 Image Analysis software (PerkinElmer).
Lineage tracing using a YFP reporter
To induce recombination at Notch1 and Rosa26 loci, YFPCreNotch1 mice were injected intraperitoneally (i.p.) with β-Naphthoflavone (BNF, MP Biomedicals, 156738) and tamoxifen (TAM, Sigma-Aldrich, N3633). To induce recombination at clonal level in the esophageal epithelium, mice were treated with BNF (80 mg kg−1) and TAM (0.125 mg)42. Excision of the Notch1 allele and expression of the YFP reporter at the Rosa26 locus can occur in the cells either in combination or separately, resulting in four different populations of cells, Notch1 mutant or not, and expressing YFP or not. Peeled epithelium was stained for NOTCH1, YFP and DNA, imaged with confocal microscopy at ×40 objective and YFP+ basal and suprabasal cells were counted. In induced Notch1flox/flox tissue, YFP + clones expressing NOTCH1 were categorized as wild type (+/+), while the clones without detectable expression of NOTCH1 were classified as Notch1−/−. For example, in YFPCreNotch1flox/flox induced mice at 4 weeks postinduction, we observed 67 ± 2% of YFP−; Notch1−/− clones; 6 ± 1% YFP+; Notch1−/− clones and 27 ± 3% of YFP+; Notch1+/+ clones (data obtained from three mice). In induced Notch+/flox tissue, YFP+ wild type (+/+) and YFP+ Notch1+/− clones were distinguished using NOTCH1 staining measurement (Supplementary Note).
EdU lineage tracing
EdU incorporates during replication in the proliferating cells located in the basal layer of the esophageal epithelium. EdU i.p. injection at 10 µg was performed either at 1 h or 48 h before tissue collection. Tissue was processed and EdU was detected in whole mount using Click-iT EdU imaging kit (Life Technologies, C10338 or C10340).
EdU/BrdU lineage tracing
Mice were injected with EdU i.p. injection at 10 µg 48 h before tissue and with BrdU i.p. at 1 mg 1 h before collection to label cells in S phase. Tissue was processed as in ‘Whole-mount sample preparation of mouse esophagus’. For immunostaining, tissue was first incubated for 30 min in permeabilization buffer (0.5% BSA, 0.25% fish skin gelatin, 0.5% Triton X-100 in PHEM) followed by 20 min at 37 °C in DNAse buffer containing 500 units DNAse under 500 rpm agitation (NEB, M0303L). Tissue was washed three times in PBS for 20 min. Samples were then processed as described in ‘whole-mount immunostaining’. EdU was detected in whole mount using Click-iT EdU imaging kit (Life Technologies, C10338). BrdU was detected using primary antibody anti-BrdU (Abcam, ab6326). PHH3 was detected using conjugated Alexa Fluor 647 Anti-Histone H3 (phospho S10) antibody (Abcam, ab196698) (Supplementary Table 31).
YFPCreNotch1 mice between 10 and 16 weeks of age were injected i.p. with BNF at 80 mg kg−1 and TAM at 1 mg for Notch1+/+ and Notch1+/flox- and at 0.25 mg for Notch1flox/flox and aged up to 78 weeks old. Notch1+/+ or noninduced mice were used as wild-type controls as indicated. A lower dose of Tamoxifen was used for the YFPCreNotch1flox/flox mice to minimize the recombination of the Notch1 allele in the corneal epithelium, possibly leading to corneal opacification and keratinization44.
Projected NOTCH1 stained area quantification
To quantify the percentage of NOTCH1+ or NOTCH1− area in the entire esophageal epithelium or the projected surface of NOTCH1− clones, whole-mount esophageal epithelia were prepared and stained for NOTCH1 and counterstained with DAPI or Sytox Blue as described in the dedicated sections. The entire epithelium was imaged using a high-precision motorized stage coupled to a Leica TCS SP8 confocal microscope. Typical settings for the acquisition of multiple z stacks were optimized 2.41 μm z step size, zoom ×1, optimal pinhole, line average 4, scan speed 400–600 Hz and a resolution of 1024 × 1024 pixels using an ×10 HC PL Apo CS Dry objective with a 0.4 numerical aperture. Images were processed using Volocity 6 software. To measure their projected surface area, we used the ‘extended focus’ visualization mode on the Volocity software. Regions of interest (ROI) were defined with ROI tool allowing surface area measurement. NOTCH1 staining was automatically detected based on the defined intensity and minimum object size.
Mice were induced with BNF/TAM at a dose that allowed full coverage of the tissue with the mutant Notch1 heterozygous or homozygous cells within 3 months. YFPCreNotch1+/flox mice were injected i.p. on two consecutive days with BNF at 80 mg kg−1 and TAM at 1 mg and YFPCreNotch1flox/flox were injected once with BNF at 80 mg kg−1 and TAM at 0.25 mg. Noninduced YFPCreNotch1 mice were used as wild-type controls. Mice were then treated with DEN (Sigma-Aldrich, N0756) in sweetened drinking water (40 mg l−1) for 24 h, 3 d a week for 8 weeks18,21. SOR (LC Chemicals, S8502) was then administered at 50 mg kg−1 (5 µl of 10 mg ml−1 solution per gram bodyweight) by i.p. injection on alternate days during 6 weeks, for a total of 21 doses33.
Mice were aged for 28 weeks after the last dose of SOR and esophageal tissue was collected. Macroscopic images of unpeeled tissue were obtained under Leica M80 zoom stereomicroscope with Leica Plan ×1.0 Objective M-Series 10450167 coupled with Leica DFC295 Camera (Leica Microsystems). Macroscopic tumors were removed and flash frozen. Esophageal tissue was whole-mount immunostained for KRT6 and DNA. The projected area of lesions was determined using ROI tool in Volocity 6 software45.
Antibody treatment validation
Antibody validation was performed in two steps. First, C57BL/6J were injected i.p. at a high dose with rat anti-Notch1 NRR hybridoma Clone 1E3.19.1 (anti-NRR1.1E3, Genentech) at 25 mg kg−1 (n = 3 mice per group). Antibody Ragweed:9652 10D9.W.STABLE mIgG2a (CTRL, Genentech) was used as control at 25 mg kg−1. Three days later, esophageal tissue was collected and processed for RT-qPCR assay and protein quantification as described in the ‘RT-qPCR’ and ‘Immune Capillary Electrophoresis assay’ (ICE) sections. At the protein level, cleaved transmembrane/intracellular regions (NTM + NICD) of NOTCH1 and NOTCH2 were quantified by ICE to determine the specificity of anti-NRR1.1E3 for NOTCH1. NICD1 staining of cryosections confirmed the absence of active NOTCH1 in anti-NRR1.1E3 treated tissue. At the transcriptional level, RT-qPCR for Notch1 loss of function markers Igfbp3, Tgm2, Gli2, Adam8 and Sox9 was performed. Second, YFPCreNotch1flox/flox mice were induced at clonal level, and starting a week later, were treated weekly with antibodies for 3 weeks. Epithelial whole mounts were then stained for NOTCH1. NOTCH1 blockade would be expected to neutralize the competitive advantage of Notch1−/− clones over wild-type cells, reducing clonal expansion21. Anti-NRR1.1E3 at 10 mg kg−1 offered the greatest reduction in NOTCH1− clone size. n = 4 mice injected with Ragweed controls at 10 mg kg−1; n = 3 mice given NRR1.1E3 at 10 mg kg−1; n = 2 mice given NRR1.1E3 10 mg kg−1 loading dose (LO: week 1, 10 mg kg−1; week 2, 7.5 mg kg−1; week 3, 5 mg kg−1); n = 1 mouse given NRR1.1E3 5 mg kg−1; and n = 1 mouse given NRR1.1E3 5 mg kg−1 loading (LO: week 1, 5 mg kg−1; week 2, 4 mg kg−1; week 3, 3 mg kg−1). Antibody NRR1.1E3 did not cause weight loss or other adverse effects.
To analyze the effect of NOTCH1 neutralizing antibody on tumor growth, uninduced YFPCreNotch1flox (wild type) mice were first treated with DEN and SOR and aged for 9 weeks to allow the tumors to start growing before starting a treatment with anti-NRR1.1E3 (Genentech) at 10 mg kg−1 or with Ragweed control (Genentech) at 10 mg kg−1 (n = 4 mice per group), once a week for 6 weeks. One week after the last dosage, tissue was collected and processed for macroscopic and microscopic quantification of the projected areas of the tumors using Volocity 6 software as described in ‘carcinogen treatment’ section.
Cell density in mouse esophagus
Density of the basal cells was measured on whole-mount stained tissue, imaged at ×40 objective using Leica TCD SP8 confocal microscope (see ‘confocal microscopy’). DAPI+ or Sytox Blue+ basal nuclei were quantified per area. For Notch1 mutant clones and control areas, analysis was performed in seven to nine clones and paired areas from three YFPCreNotch1+/flox mice at 13 weeks postinduction and in three to seven clones and paired areas from seven YFPCreNotch1flox/flox mice at 4 weeks postinduction. For aged mouse tissue, analysis was performed at three to six random positions of the tissue, n = 4 mice per genotype.
Cell counting and epithelial thickness
Epithelial thickness was quantified in cryosections stained with H&E with NanoZoomer Digital Pathology software (NDP.view2, Hamamatsu). Measurements were performed at 18–23 positions and averaged for each mouse (n = 3 mice). For cell counting, stained sections were imaged by confocal microscopy and analyzed with Volocity 6 software (Perkin Elmer). Ki67+ basal cells were counted at three different positions per animal and averaged for each mouse (n = 3–4 mice). For tumor cells in G2/M phase, cryosections were stained for pHH3, CCNB1, KRT14 and DNA (n = 8 tumors from four wild-type mice; n = 9 tumors from seven mutant mice). For NICD1, sections of tumors and adjacent normal tissue were stained for NICD1, KRT14 and DNA. The proportion of KRT14+ keratinocytes expressing nuclear NICD1 inside the tumor mass and in the adjacent normal epithelium was quantified (n = 10 tumors from six mice).
Fluorescence intensity quantification in tumors and normal tissue
Esophageal sections carrying tumors and adjacent normal tissue stained for CDH1 (E-cadherin), KRT14, and counterstained with DAPI were imaged using a Leica TCD SP8 confocal microscope. Mean intensity was quantified in ROI with the ROI tool in Volocity 6 software. Mean intensity of CDH1 was normalized to the mean intensity of DAPI at each ROI (Supplementary Table 24). For phospho-ERK1/2 (p-ERK) and total ERK1/2 (total ERK), sections were costained for KRT14 and DAPI, and were analyzed as above with the following modifications: within ROI defined on KRT14+ cells in adjacent normal or inside the tumors, p-ERK staining was automatically detected using the ‘find objects’ function of Volocity 6 software, using 12-255 intensity threshold and a minimum object size of 0.5 µm2 and a restrictive radius of 2 µm. p-ERK staining was performed in all tumor sections simultaneously. For CDH1, p-ERK and Total ERK quantifications, we verified that staining was not affected in normal tissue of DEN/SOR treated Notch1−/− mice compared to wild-type mice on tissues stained together on the same slide (n = 3 mice, Supplementary Table 24).
DNA, RNA and scRNA-seq
Methods for sample processing and analysis of sequencing data (DNA sequencing, RNA bulk sequencing and scRNA-seq) are detailed in the Supplementary Note.
Stochastic simulations of clonal dynamics are explained in the Supplementary Note.
Data are expressed as mean values ± s.e.m. unless otherwise stated. P values <0.05 were considered significant. Each experiment was performed using several biological replicates, with the exception of technical replicates only for primer validation using standard curves. The numbers of replicates are stated in the legends and in the Supplementary tables. Statistical tests are indicated in figure legends and were performed using GraphPad Prism software 8.3.1 and Python package Scipy 1.7.3 (https://scipy.org/citing-scipy/). No statistical method was used to predetermine sample size. Animals of the correct genotype were randomly assigned to experimental groups.
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Accession numbers for the datasets are as follows: targeted sequencing of Human esophageal epithelium microbiopsies data is deposited in the European Genome-Phenome Archive under the accession code EGAD00001006969. All other sequences are deposited in the European Nucleotide Archive under the following accession codes: targeted sequencing of aged Notch1+/− mouse esophageal epithelium microbiopsies; ERP126992, targeted sequencing of mouse normal esophageal epithelium 28 weeks after DEN SOR treatment; ERP126993, targeted sequencing of mouse esophageal tumors 28 weeks after DEN SOR treatment; ERP126994, transcriptomic analysis of Notch1 mutant esophageal epithelium; ERP126995, single-cell transcriptional analysis of Notch1 mutant esophageal epithelium; ERP126996, transcriptomic analysis of Notch1 mutant esophageal tumors and adjacent normal tissue 28 weeks after DEN SOR treatment; ERP137375.
All numerical data displayed in the figures are shown in Supplementary Tables 2–30.
Mouse strains are available from the Jax repository (https://www.jax.org), except the AhcreERT line, which may be obtained by contacting the corresponding author. Source data are provided with this paper.
The codes developed in this study has been made publicly available and can be found at https://github.com/PHJonesGroup/Abby_etal_SI_code.
Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911–917 (2018).
Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).
Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).
The Cancer Genome Atlas Research Network Integrated genomic characterization of oesophageal carcinoma. Nature 541, 169–175 (2017).
Aster, J. C., Pear, W. S. & Blacklow, S. C. The varied roles of notch in cancer. Annu. Rev. Pathol. 12, 245–275 (2017).
Lloyd-Lewis, B., Mourikis, P. & Fre, S. Notch signalling: sensor and instructor of the microenvironment to coordinate cell fate and organ morphogenesis. Curr. Opin. Cell Biol. 61, 16–23 (2019).
Kovall, R. A., Gebelein, B., Sprinzak, D. & Kopan, R. The Canonical Notch Signaling Pathway: structural and biochemical insights into shape, sugar, and force. Dev. Cell 41, 228–241 (2017).
Zhang, Y. et al. 3D modeling of esophageal development using human PSC-derived basal progenitors reveals a critical role for notch signaling. Cell Stem Cell 23, 516–529 (2018).
Lubin, D. J., Mick, R., Shroff, S. G., Stashek, K. & Furth, E. E. The notch pathway is activated in neoplastic progression in esophageal squamous cell carcinoma. Hum. Pathol. 72, 66–70 (2018).
Natsuizaka, M. et al. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat. Commun. 8, 1758 (2017).
Sawangarun, W. et al. Loss of Notch1 predisposes oro-esophageal epithelium to tumorigenesis. Exp. Cell. Res. 372, 129–140 (2018).
Bray, S. J. & Gomez-Lamarca, M. Notch after cleavage. Curr. Opin. Cell Biol. 51, 103–109 (2018).
Mesa, K. R. et al. Homeostatic epidermal stem cell self-renewal is driven by local differentiation. Cell Stem Cell 23, 677–686 (2018).
Doupe, D. P. et al. A single progenitor population switches behavior to maintain and repair esophageal epithelium. Science 337, 1091–1093 (2012).
Piedrafita, G. et al. A single-progenitor model as the unifying paradigm of epidermal and esophageal epithelial maintenance in mice. Nat. Commun. 11, 1429 (2020).
Murai, K. et al. Epidermal tissue adapts to restrain progenitors carrying clonal p53 mutations. Cell Stem Cell 23, 687–699 (2018).
Alcolea, M. P. et al. Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change. Nat. Cell Biol. 16, 615–622 (2014).
Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547–558 (1999).
Lowell, S., Jones, P., Le Roux, I., Dunne, J. & Watt, F. M. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr. Biol. 10, 491–500 (2000).
Colom, B. et al. Spatial competition shapes the dynamic mutational landscape of normal esophageal epithelium. Nat. Genet. 52, 604–614 (2020).
Rand, M. D. et al. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol. Cell. Biol. 20, 1825–1835 (2000).
Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382–W388 (2005).
Fowler, J. C. et al. Selection of oncogenic mutant clones in normal human skin varies with body site. Cancer Discov. 11, 340–361 (2020).
Gordon, W. R. et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood 113, 4381–4390 (2009).
Chiang, M. Y., Radojcic, V. & Maillard, I. Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders. Curr. Opin. Hematol. 23, 362–370 (2016).
Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941–d947 (2019).
Clayton, E. et al. A single type of progenitor cell maintains normal epidermis. Nature 446, 185–189 (2007).
Lee, J., Basak, J. M., Demehri, S. & Kopan, R. Bi-compartmental communication contributes to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal keratinocytes. Development 134, 2795–2806 (2007).
Blanpain, C., Lowry, W. E., Pasolli, H. A. & Fuchs, E. Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev. 20, 3022–3035 (2006).
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
McGinn, J. et al. A biomechanical switch regulates the transition towards homeostasis in oesophageal epithelium. Nat. Cell Biol. 23, 511–525 (2021).
Frede, J., Greulich, P., Nagy, T., Simons, B. D. & Jones, P. H. A single dividing cell population with imbalanced fate drives oesophageal tumour growth. Nat. Cell Biol. 18, 967–978 (2016).
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041 (2017).
Liu, L. H., Boivin, G. P., Prasad, V., Periasamy, M. & Shull, G. E. Squamous cell tumors in mice heterozygous for a null allele of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump. J. Biol. Chem. 276, 26737–26740 (2001).
Prasad, V. et al. Haploinsufficiency of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. Cancer Res. 65, 8655–8661 (2005).
Stairs, D. B. et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell 19, 470–483 (2011).
Wu, Y. et al. Therapeutic antibody targeting of individual Notch receptors. Nature 464, 1052–1057 (2010).
Celli, A. et al. SERCA2-controlled Ca2+-dependent keratinocyte adhesion and differentiation is mediated via the sphingolipid pathway: a therapeutic target for Darier’s disease. J. Invest. Dermatol. 132, 1188–1195 (2012).
Hong, J. H. et al. Markers of squamous cell carcinoma in sarco/endoplasmic reticulum Ca2+ ATPase 2 heterozygote mice keratinocytes. Prog. Biophys. Mol. Biol. 103, 81–87 (2010).
van Neerven, S. M. et al. Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature 594, 436–441 (2021).
Kemp, R. et al. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res. 32, e92 (2004).
Fernandez-Antoran, D. et al. Outcompeting p53-mutant cells in the normal esophagus by redox manipulation. Cell Stem Cell 25, 329–341 (2019).
Movahedan, A. et al. Loss of Notch1 disrupts the barrier repair in the corneal epithelium. PLoS ONE 8, e69113 (2013).
Colom, B. et al. Mutant clones in normal epithelium outcompete and eliminate emerging tumours. Nature 598, 510–514 (2021).
This work is supported by grants from the Wellcome Trust to the Wellcome Sanger Institute (098051 and 296194) and Cancer Research UK Program Grants to P.H.J. (C609/A17257 and C609/A27326). E.A. benefited from the award of a Postdoctoral fellowship, 2016–23, from the Wellcome Sanger Institute. B.A.H. and M.W.J.H. are supported by the Medical Research Council (Grant-in-Aid to the MRC Cancer unit grant MC_UU_12022/9 and NIRG to B.A.H. grant MR/S000216/1). M.W.J.H. acknowledges support from the Harrison Watson Fund at Clare College, Cambridge. B.A.H. acknowledges support from the Royal Society (grant UF130039). S.C.D. benefited from the award of an ESPOD fellowship, 2018–21, from the Wellcome Sanger Institute and the European Bioinformatics Institute EMBL-EBI. G.P. is supported by the Agencia Estatal de Investigación of Spain (grant PID2020-116163GA-I00). A.H. benefited from the award of an EMBO long-term fellowship (EMBO ALTF885-2015) and a Maria Zambrano Grant to attract international talent from Universitat de Barcelona and Ministerio de Universidades and cofunded with Next Generation EU funds. We thank the following staff from the Wellcome Sanger Institute. E. Choolun, T. Metcalf and staff from the RSF facility for technical support with animal research; Y. Hooks, C. Hardy, C. Latimer and staff from the Cancer, Ageing, and Somatic Mutations program support laboratory and staff from the bespoke team for technical support with histology and sequencing.
The authors declare no competing interests.
Peer review information
Nature Genetics thanks Francesca Ciccarelli, Joshua Snyder and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
a. NOTCH1 is composed of an extracellular domain (NEC) and a transmembrane and cytoplasmic unit (NTM). Domains of NOTCH1 are indicated, arrows show epitopes recognized by anti-NOTCH1 (blue) and anti-NICD1 (orange) antibodies. Ligand binding results in proteolytic cleavages, after which the intracellular domain (NICD) migrates to the nucleus and activates transcription. Domains: EGF, epidermal growth factor like repeats, LNR, Lin12/Notch repeats, HD, heterodimerization, TM, transmembrane, RAM, RBP-J associated module, ANK, ankyrin repeats, TAD, trans-activation domain, PEST, rich in proline, glutamate, serine, and threonine, NRR, negative regulatory region. b. Human esophageal epithelium. Proliferation is confined to the lower layers. Differentiating cells migrate to tissue surface. Pa, papillae. Protein expression shown on right. c. Representative section stained for NOTCH1 (red) and DNA (blue) showing subset of results in Fig. 1b for donor PD31008. Left: sample identification (Id), NOTCH1 staining status (+ or −). Right: non-synonymous NOTCH1 mutations, variant allele frequency (VAF) and copy neutral loss of heterozygosity (CNLOH) if detected, with B allele frequency (BAF) value. Mutation effects: Indel_Splicing, gray; Missense, blue; Nonsense, red. Dashed lines delineate epithelium and submucosa (white) and borders of sequenced samples (yellow). Scale bar, 250 µm. d. Copy number calls for samples PD31008bc and bd, shown in c, Fig. 1d–f and Supplementary table 4. Left plot, analysis of total copy number along chromosome 9 for samples bc and bd. Middle, right plots, BAF along chromosome 9 and NOTCH1 locus, respectively. Red lines denote significant difference from control, black lines indicate no significant difference. e. Successive sections of esophagus from older donors stained for NICD1, Ki67 and Hematoxylin and eosin (H&E). Images representative of 4 donors. Scale bars, 100 µm. f, g, h. Tissue thickness (f), cell density (g) and proportion of proliferative cells (h) in NICD1 positive and negative areas. Each dot represents a donor. For f, NICD1+, n = 14 areas from 4 donors, NICD1−, n = 15 areas from 4 donors. For g, NICD1+: 10795 cells from 4 donors, NICD1−: 11593 cells form 4 donors. For h, NICD1+: 5402 cells from 4 donors, NICD1−: 6204 cells from 4 donors. Two-tailed paired t-test. See Supplementary Tables 1–5.
a. Structure and cellular homeostasis in mouse esophageal epithelium. The basal layer contains progenitor cells that divide to generate progenitor and differentiating daughter cells. Differentiating basal layer cells exit the cell cycle and migrate into the suprabasal layers, moving towards the surface of the epithelium from which they are shed. The division of a progenitor cell (green) produces two progenitors, two differentiating cells or one cell of each type. In homeostatic tissue, the likelihood of each division outcome is balanced and gives on average 50% of progenitors and 50% of differentiating cells across the progenitor population. b. YFPCreNotch1 conditional knock-out mouse strain. LoxP sites (gray arrows) flank exon1 of the Notch1 gene. Notch1flox animals were crossed with Rosa26floxedYFP mice carrying a conditional yellow fluorescent protein (YFP) reporter targeted to the Rosa26 locus and with AhCreERT mice carrying an inducible Cre recombinase. c. For lineage tracing, triple mutant mice were treated with inducing drugs at a dose that resulted in recombination of Notch1 (blue), expression of YFP (green) or both (orange) in scattered individual esophageal basal cells (clonal induction). The recombined cells may expand into clones detected by the reduced intensity (+/−) or absence of NOTCH1 (−/−) and expression of YFP detected by immunostaining. Samples were collected at different time points after induction and the number and location of cells in each clone determined by 3D confocal imaging of sheets of epithelium. d. Triple mutant mice were induced with a high dose of drugs, allowing recombination of cells at high density in the tissue. In the case of mutant clones with a competitive advantage over wild type cells, this protocol allowed the coverage of the tissue by mutant clones relatively shortly after induction.
Extended Data Fig. 3 Monoallelic and biallelic recombination at Notch1 locus results in reduction of Notch1 mRNA and protein.
a. Protocol for b, f-h. Highly induced YFPCreNotch1flox/flox or +/flox mice aged to allow Notch1 mutant cells to colonize epithelium. Controls, non-induced mice (+/+). b. Esophageal sections 10 days post induction (p.i.) stained for NOTCH1 (magenta), Wheat germ agglutinin (WGA) (gray) and DNA (blue). Scale bars, 30 µm. c. Quantitative PCR assay for Notch1 recombination. Primer set B measures floxed exon1, C amplifies recombined locus, A allows normalization. d, e. Validation using set B (d) and set C (e) against standard curve (Mean ± SEM, n = 3 technical replicates). f-h. YFPCreNotch1flox/flox or +/flox mice and controls aged for 8 weeks, mean ± SEM, each dot represents a mouse, n = 4 mice. f. Exon1/Exon3 ratio assay using set B. One-way ANOVA; adjusted p values from Tukey’s multiple comparisons test against wild type. g. Notch1:Gapdh mRNA by RT-qPCR. One-way ANOVA; adjusted p values from Tukey’s multiple comparisons test against wild type. h. Immune Capillary Electrophoresis of NOTCH1 transmembrane/intracellular domain (NTM1 + NICD1) and α-Tubulin protein. Dashed lines indicate image cropping and arrangement. One-way ANOVA; adjusted p values from Tukey’s multiple comparisons test against wild type. i. Protocol. YFPCreNotch1flox/flox or +/flox or +/+ mice were clonally induced, whole mounts stained for NOTCH1, YFP and DAPI. Clones were identified by NOTCH1 staining (Extended data Fig. 2a, Supplementary Note). j. Epithelium stained for NOTCH1 (magenta), YFP (green) and DNA (blue) 13 weeks p.i. of YFPCreNotch1flox/flox or +/flox or +/+ mice. Scale bars, 500 µm. k-n. Validation of clonal genotype. k. Protocol. Tissues were stained for NOTCH1, YFP and DNA at 4 weeks p.i. for YFPCreNotch1flox/flox and 13 weeks p.i for YFPCreNotch1+/flox. Potential clones were micro-dissected (yellow dotted lines) and qPCR performed using set C. l, m. Representative examples of 4 weeks post-induction (w.p.i.) Notch1−/− clones and control areas (upper panels) and 13 w.p.i. Notch1+/− clones and control areas (lower panels) validated as in k. NOTCH1, magenta, YFP, green, DNA, blue. l. Projected view. Dotted lines: orange, dissected clones, blue, control areas. Scale bars, 125 µm. m. (x, y) basal view. White dotted lines: clone edges. Scale bars, 30 µm. n. qPCR assay using primer set C (c, e). Mean± SEM, each dot represents a sample, n = 22 controls and n = 21+/− clones from 3 YFPCreNotch1+/flox mice; n = 21 controls and n = 22 −/− clones from 3 YFPCreNotch1flox/flox mice. Two-tailed unpaired Student t-test. AU, arbitrary units. SEM, standard error of mean. See Supplementary Table 6.
a. 2-dimensional Wright-Fisher style model of clone dynamics. The basal layer consists of a hexagonal grid of cells. At time zero, a small proportion of cells is mutant (red) and the rest wild type (gray). Cells in the next generation are picked from neighboring cells – for example the cells which can be placed in the outlined position in generation 2 are those marked with an X in generation 1. Mutant cells with higher fitness have a higher probability of generating daughters in the next generation and expand into large clones (Supplementary Note). b. Inferred induction proportion and inferred fitness values from ABC fitting to the lineage tracing data (Supplementary Note) for Notch1−/− (red), Notch1+/− (purple) and Notch1+/+ (black) clones in the respective animals. Each dot shows an ‘accepted’ parameter set. A fitness of 1 (dotted line) is neutral. c. Distributions of acceptable values of the fitness parameter. Whiskers show the upper and lower bounds of the 95% credible interval, boxes show quartiles, center lines indicate medians of credible intervals. A fitness of 1 (blue dotted line) is neutral. d. Mean clone sizes from simulations of the parameters at the peak of acceptable distributions (see Supplementary note). Median and 95% confidence intervals of 100 simulations shown for the simulation curves. Mean ± standard error of mean are shown for the experimental data. e. Proportion of tissue covered by Notch1−/− clones over time in simulations using the best-fit for Notch1−/− fitness. Notch1+/− is either assumed to be neutral (haplosufficient, green) or to have the best fitting fitness parameter to the experimental analysis of Notch1+/− clones (haploinsufficient, orange). Curves show median and shaded areas show 95% confidence intervals of 100 simulations. f. Representative snapshot images at 100 days, 300 days and 3000 days from the simulations shown in e. On the left, Notch1+/− cells are haploinsufficient (fitting to experimental data), on the right the Notch1+/− cells are assumed to be haplosufficient (neutral fitness). Cells from each genotype are color coded. All images show the same number of cells/area of simulated tissue. See Supplementary Note.
a. Protocol. YFPCreNotch1 +/flox mice were induced at high density and aged. b. Representative sections stained for NICD1 (magenta), KRT14 (green), and DNA (blue) from Notch1+/− mice 13 weeks (n = 3) and 65 weeks (n = 5) after induction. Scale bars, 25 µm. c, d. Copy neutral loss of heterozygosity (CNLOH) analysis from Fig. 3e sequencing showing a representative non-clonal area (c, sample MD6364e) and a NOTCH1 negative clone (d, sample MD6364j). Coverage of off-target reads (left), and B allele fraction (BAF, middle and right) along chromosome 2 (middle) and at Notch1 locus (right). Red lines indicate significant, black lines, no significant difference. e. Left: EDTA treatment activates NOTCH1 cleavage without ligand. Right: representative NOTCH1 positive areas of aged Notch1+/− esophagi stained for NOTCH1 (red), YFP and DNA (blue). Images show non-EDTA control and EDTA treated sequenced tissue as in Fig. 3e–g (control area, nuclear or non-nuclear clones). Scale bars, 25 µm. f. Notch1 mutations in clones with or without NOTCH1 nuclear staining, n mutations in brackets. Mutation effects are color coded. g. Location of missense Notch1 mutations in nuclear and non-nuclear staining clones, n samples in brackets. P = 0.001, Chi-square test. h. Distribution of Notch1 missense mutations in nuclear (purple, n = 42) and non-nuclear staining (orange, n = 20) clones. EGF, Epidermal Growth Factor like repeats, LNR, Lin12/Notch repeats and ANK, ankyrin repeats shown. Purple shadow: EGF repeat 8-12 mutations, Orange shadow: LNR repeat mutations. i. Missense mutations (n = 21) in NOTCH1 EGF8-12 in nuclear staining samples. Mutations highlighted on structure of rat NOTCH1 EGF8-12 bound to JAGGED-1 (PDB 5UK5, https://www.rcsb.org/). Mutated residues: dark red, calcium binding; yellow, residues on interface with JAGGED-1; purple, highly destabilizing mutations (FoldX ∆∆G > 2 kcal/mol). R365C, is blue, calcium ions in green. j. Mutations shown on human negative regulatory region (NRR) (PDB 3ETO, https://www.rcsb.org/). Orange, n = 9 missense mutations from non-nuclear staining clones. Blue, missense mutations from human T-cell acute lymphoblastic leukemia (https://cancer.sanger.ac.uk/cosmic ref. 27). Proportion of missense mutations between LNR1-2 and LNR3-HD in T-ALL and non-nuclear staining clones is significantly different (Two-sided Fisher exact tests, p = 1.48e−10 n = 153 mutations). LNR1, blue; LNR2, pink; LNR3, green; HD domains, yellow. See Supplementary Tables 10 and 11.
a. RNA-seq (n = 4 mice per group) was performed on epithelium from highly induced YFPCreNotch1flox/flox and YFPCreNotch1+/flox mice, aged for 8 weeks to allow mutant colonization. Uninduced mice were used as controls (+/+). b. Principal component analysis (PCA) plot showing Notch1+/+, Notch1+/− and Notch1−/− samples in two dimensions. Dotted lines indicate the origin of the axes. Sample genotypes are color-coded. c. Hierarchical clustering and heat map showing differentially expressed genes between Notch1−/− and control tissues, in all three genotypes. d. Heat maps showing Log2 fold changes of 25 top differentially expressed genes in Notch1−/− compared to Notch1+/+ tissues, adjusted p-value < 0.05. e. Gene Set Enrichment Analysis of Notch1−/− tissue vs Notch1+/+ tissue. Bar chart shows normalized enrichment scores (NES) for the four most significantly downregulated gene sets in Notch1−/− tissue vs Notch1+/+ tissue and the most significantly upregulated gene set. False discovery rate (FDR) q-value <0.05. See Supplementary Tables 12–15.
a. qPCR recombination assay of Notch1 exon1 in epithelium from YFPCreNotch1flox/flox mice induced as for single cell RNA-seq (scRNA-seq)and collected 4 weeks later, compared with wild type tissue. Mean ± SEM, each dot represents a mouse, n = 3 mice. Two-tailed unpaired Student’s t-test. b-d. scRNA-seq as in Fig.4a (n = 2 mice per genotype; +/+1, n = 2454; +/+2, n = 3194; −/−1, n = 1929; −/−2, n = 5534). Uniform Manifold Approximation and Projection (UMAP) plots show markers of fibroblasts (Zeb1, b), endothelial cells (Pecam1/ CD31, c) and immune cells (Ptprc /CD45, d). See Supplementary Note. e-g. Sections from Notch1+/+ and Notch1−/− esophagi show KRT14 basal keratinocyte marker, green, DNA, blue and fibroblasts (ZEB1, e), endothelial cells (CD31, f) and immune cells (CD45, g), magenta. Images representative of 3 mice per genotype. Scale bars, 25 µm. h-k. UMAP plots show markers of keratinocyte differentiation highlighting basal cells (Krt14, h), differentiating cells (Tgm3, i, Krt4,j) and cornified cells (Lor, k). Dashed black line separates basal cells and suprabasal cells (Supplementary Note). (+/+1, n = 1555; +/+2, n = 1932; −/−1, n = 1403; −/−2, n = 3919). l. YFPCreNotch1flox/flox mice were highly induced or not induced (+/+ controls) and aged for 8 weeks, then EdU was injected 48 h and BrdU 1 h before collection. EdU+ cells are shown in red; BrdU+ cells are green; EdU+; BrdU+ cells are yellow. m. Notch1−/− and Notch1+/+ epithelia stained for EdU (red), BrdU (S phase, green), pHH3 (G2/M, gray) and DNA (blue). Scale bars, 25 µm. n, o. Ratio of EdU + ; BrdU+ basal cells (S phase, n) or EdU+; BrdU-; pHH3 + (G2/M, o)/total EdU+ basal cells in Notch1+/+ and Notch1−/− epithelia (n = 3856 Notch1+/+ EdU+ basal cells from 4 mice, n = 2328 Notch1−/− basal cells from 3 mice). p. EdU+ suprabasal: total EdU+ cells ratio (n = 6696 EdU+ Notch1+/+ cells from 4 mice; n = 4203 EdU+ Notch1−/− cells from 3 mice). q, r. BrdU+ basal cells (S phase, q) or BrdU−; pHH3+ basal cells (G2/M, r) /total basal cells in Notch1+/+ and Notch1−/− epithelia (n = 22669 Notch1+/+ basal cells from 4 mice, n = 16111 Notch1−/− basal cells from 3 mice). For n-o, Mean ± SEM, each dot represents a mouse, two-tailed unpaired Student’s t-tests. AU, arbitrary unit. SEM, standard error of mean. See Supplementary Tables 16 and 17.
a–c. Mouse esophageal epithelium and tumors from Notch1+/+ esophagus and tumors from Notch1−/− esophagus (from protocol in Fig.7a) were processed for targeted sequencing. a. Proportion of tissue mutant for Notch1 and Atp2a2 in tumors from Notch1+/+ esophagus and in adjacent epithelium, estimated from sum of variant allele frequencies (VAFs) of non-synonymous mutations for Notch1 and Atp2a2 (n = 115 normal epithelial biopsies from 6 mice, n = 17 tumors from 7 mice; Supplementary Note). b. Summed VAF of protein altering mutations in the indicated genes is shown for random Notch1 +/+ epithelial samples (upper, n = 17/115), all 17 sequenced tumors from Notch1+/+ (lower left) and all 7 tumors from Notch1−/− esophagus (lower right). c. Proportion of tissue mutant for Notch1 and Atp2a2 estimated from sum of VAFs of non-synonymous mutations for each gene in tumors from Notch1−/− esophagus. (n = 7 tumors from 5 mice; Supplementary table 26; Supplementary Note). d-h, Protocol. Tumors from Notch1+/+ and Notch1−/− esophageal epithelia (Fig. 7a) were sectioned and characterized by immunostaining. d. Tumors were stained, from left to right, for Hematoxylin and eosin (H&E), differentiation markers (KRT14 and LOR), endothelial marker CD31 and DNA, gray. e. Tumors were stained, from left to right, for active NOTCH1 (NICD1), immune cell marker CD45, apoptosis marker cleaved Caspase 3 in magenta, KRT14, green and DNA, blue. For d, e, images representative of n = 10 wild type tumors, n = 11 Notch1−/− tumors for all immunostainings, n = 4 for cleaved Caspase 3. Scale bars in d, 500 µm, in e, 30 µm. f. Tumors were stained for E-cadherin (CDH1, gray) and DNA (blue). Right panels, magnified views of white squares. Arrows indicate keratinocytes with reduced CDH1 staining. Images are representative of n = 8 tumors from 6 mice of each genotype. Scale bars, 100 µm (left panel) and 30 µm (right). g,h. Mean CDH1 intensity relative to DNA in tumor compared to adjacent epithelium in Notch1+/+ (g) and Notch1−/− (h) (n = 8 tumors from 6 mice for each genotype). Two tailed paired Student’s t-test. AU, arbitrary unit. See Supplementary Tables 19, 20, 24 and 26.
a. Protocol for b-e. C57Bl/6 wild type mice were treated with anti-NRR1.1E3 or control antibody (CTRL) for three days before tissue collection. b, c. Immune Capillary Electrophoresis was performed on peeled esophageal epithelia of mice in a. Visual representation of cleaved transmembrane and intracellular regions of NOTCH1 (NTM1 + NICD1, top panel, Extended data Fig. 1a) and of NOTCH2 (NTM2 + NICD2, bottom panel), and α-Tubulin proteins. Dashed lines indicate image cropping (b). Proteins expression relative α-Tubulin. Mean ± SEM, each dot represents a mouse, n = 3 mice. Two-tailed unpaired Student’s t-test (c). d. Representative images of staining for NICD1 (magenta), KRT14 (green) and nuclei (blue) in sectioned epithelium of 3 mice treated with control or anti-NRR1.1E3 antibodies. Scale bars, 25 µm. e. RT-qPCR for markers of Notch1 loss of function identified by bulk RNA-seq analysis (Extended data Fig. 6d, Supplementary Table 12) relative to Gapdh transcript in control and anti-NRR1.1E3 treated samples. Mean ± SEM, each dot represents a mouse, n = 3. Two-tailed unpaired Student’s t-test. f. Protocol. YFPCreNotch1flox/flox mice were induced at clonal density. One week later, mice were treated with anti-NRR1.1E3 or control antibodies for 3 weeks. g. Principle of assay shown in f, If anti-NRR1.1E3 treatment blocks NOTCH1 signaling, all cells have equal fitness and expansion of Notch1−/− clones is halted21. h. Representative images of NOTCH1 negative clones in EDTA peeled esophageal epithelia treated with control or anti-NRR1.1E3 antibody from 3 mice. Scale bars, 50 µm. i. Projected area of clones negative for NOTCH1 staining. Mean ± SEM, each dot represents a clone. Number of mice analyzed is in brackets. One-way ANOVA; Tukey’s multiple comparisons test, adjusted p-values versus control antibody. AU, arbitrary unit. SEM, standard error of mean. LO, loading. See, Supplementary table 25.
Extended Data Fig. 10 Transcriptomic characterization and cellular phenotype of tumors from Notch1+/+ and Notch1−/− esophagus.
a-d. RNA-seq analysis of Notch1+/+ and Notch1−/− esophageal tissue and tumors, see Fig. 8a. a. Principal component analysis (PCA) plot showing in two dimensions all biological replicates from Notch1+/+ normal epithelium (n = 11 biopsies from 7 mice, green), tumors from Notch1+/+ epithelium (n = 8 tumors from 4 mice, red), Notch1−/− normal epithelium (n = 10 biopsies from 7 mice, blue) and tumors from Notch1−/− epithelium (n = 6 tumors from 5 mice, orange). Dotted lines indicate the origin of the axes. b. Hierarchical clustering and heat map showing differentially expressed genes between tumors and adjacent normal tissue, in Notch1+/+ mice (left) and Notch1−/− mice (right). c. Hierarchical clustering and heat map showing differentially expressed genes between tumors from Notch1+/+ and Notch1−/− esophagus. d. Gene Set Enrichment Analysis (GSEA) of tumors from Notch1−/− vs Notch1+/+esophagus. Normalized enrichment score (NES) of altered Biological Process gene sets in tumors. False discovery rate, FDR q-value<0.05. e. Representative images of n = 8 tumors from Notch1+/+ and n = 9 tumors from Notch1−/− esophagus. KRT14 (green), CCNB1 (magenta). DNA, blue. Scale bars, 30 µm. f. Percentage of CCNB1 positive; KRT14 expressing keratinocytes within tumors from Notch1+/+ and Notch1−/− esophagus. Mean ± SEM, each dot represents a tumor, +/+: n = 8 tumors from 4 mice; −/−: n = 9 tumors from 7 mice. Two-tailed unpaired Student’s t-test. See Supplementary Tables 24 and 27–29.
Supplementary Table 1: List of genes in the targeted sequencing experiments performed in this study. Supplementary Table 2: Targeted sequencing of human esophageal epithelium microbiopsies; Complete mutation calling from Caveman and Pindel pipelines (part 1) and from Shearwater (part 2). Supplementary Table 3: dNdS analysis of the human microbiopsies sequencing. Supplementary Table 4: NOTCH1 mutations summary in human esophageal epithelium microbiopsies. Supplementary Table 5: Human samples metadata and analysis of NOTCH1; NICD1 areas in the human esophageal epithelium. Supplementary Table 6: Notch1 transcriptional and protein expression in Notch1 wild type, Notch1+/− and Notch1−/− tissue. Supplementary Table 7: Genetic lineage tracing of Notch1 mutant clones. Supplementary Table 8: EdU lineage tracing and cell density in expanding mutant clones. Supplementary Table 9: NOTCH1 negative areas quantification in ageing mice. Supplementary Table 10: Notch1 mutations and CNLOH analysis in NOTCH1 stained Notch1+/− microbiopsies. Supplementary Table 11: Mutation calling in microbiopsies from aged Notch1+/− esophageal epithelium. Supplementary Table 12: Differentially expressed genes (DEG) in Notch1 mutant mouse esophageal epithelium. Supplementary Table 13: Functional annotation of DEG in Notch1−/− versus Notch1+/+ and Notch1+/− versus Notch1+/+ esophageal epithelium. Supplementary Table 14: Differential expression analysis of canonical Notch targets in Notch1−/− mouse tissue. Supplementary Table 15: Gene set enrichment analysis in Notch1−/− versus Notch1+/+ esophageal epithelium. Supplementary Table 16: Single-cell transcriptomic analysis of Notch1−/− and Notch1+/+ mouse esophageal epithelium. Supplementary Table 17: Cell dynamics tracking in Notch1−/− and Notch1+/+ mouse esophageal epithelium. Supplementary Table 18: Morphological and cellular characterization of aged Notch1 mutant esophageal epithelium in mice. Supplementary Table 19: Mutation calling from targeted sequencing of DEN SOR treated esophageal epithelium. Supplementary Table 20: Mutation calling from targeted sequencing of esophageal tumors 28 weeks post-DEN and SOR treatment. Supplementary Table 21: dNdS analysis in normal mouse esophageal epithelium after DEN SOR treatment. Supplementary Table 22: dNdS analysis in mouse esophageal tumors. Supplementary Table 23: Immunohistological analysis of NOTCH1 expression and activity in mouse esophageal tumors. Supplementary Table 24: Effect of Notch1 loss and neutralization of function on tumorigenesis. Supplementary Table 25: Validation of the efficacy, specificity and tolerability of the anti-NRR1.1E3 treatment. Supplementary Table 26: Mutation calling from targeted sequencing of Notch1−/− esophageal tumors 28 weeks post-DEN and SOR treatment. Supplementary Table 27: Differentially expressed genes in Notch1 mutant esophageal tumors and adjacent normal tissue 28 weeks after DEN SOR treatment. Supplementary Table 28: Functional annotation of DEG in Notch1−/− or Notch1+/+ tumors versus normal tissue 28 weeks after DEN SOR treatment. Supplementary Table 29: Gene set enrichment analysis in Notch1−/− versus Notch1+/+ tumors 28 weeks after DEN SOR treatment. Supplementary Table 30: TPM values of cell cycle and DNA replication genes selected from GSEA in Notch1−/− versus Notch1+/+ tumors 28 weeks after DEN SOR treatment. Supplementary Table 31: Antibodies used for immunostaining. Supplementary Table 32: Primers and probes used for qPCR assays. Supplementary Table 33: Inferred fitness parameter values from ABC fitting to lineage tracing data. Supplementary Table 34: Inferred induction proportion parameter values from ABC fitting to lineage tracing data. Supplementary Table 35: Resolving Notch1 mutant clones in clonally induced Notch1+/− esophageal epithelium. Supplementary Table 36: Thresholds of base and mapping quality. Supplementary Table 37: Thresholds for heterozygous SNPs. Supplementary Table 38: Parameters used for segmentation. Supplementary Table 39: Parameters for BAF testing.
In silico simulations showing clonal expansion in YFPCreNotch1 mutant mouse model over a period of 30 d after clonal induction. The top video (+/+) shows YFP+ Notch1+/+ cells (green) expanding within a wild-type epithelium (magenta). The middle video (+/−) shows YFP+ Notch1+/+ and YFP+ Notch1+/− clones (green) as well as YFP− Notch1+/− (purple) evolving in a wild-type tissue (magenta). The bottom video (−/−) shows YFP+ Notch1+/+ and YFP+ Notch1−/− clones (green) as well as YFP− Notch1−/− (blue) evolving in a wild-type tissue (magenta). Two-dimensional Wright–Fisher style model of clone dynamics in the esophagus and parameter fitting is described in Extended Data Fig. 4 and Supplementary Note.
In silico simulations showing the effect of Notch1 haploinsufficiency (HI) on the appearance of spontaneous Notch1−/− clones in the epithelium. The top video shows the scenario of Notch1 HI, using the best-fit fitness parameter to the experimental analysis of Notch1+/− clones. The bottom video shows the scenario of Notch1+/− fitness being neutral (haplosufficiency, HS). Notch1+/− clones are shown in purple, Notch1−/− emerging by selection from Notch1+/− cells are shown in red and wild-type cells are shown in light blue. Simulation results are shown over a period of 5,000 d after the scattered induction Notch1+/− clones. In both cases, the best-fit fitness parameter for Notch1−/− fitness was used. See Extended Data Fig. 4 and Supplementary Note.
About this article
Cite this article
Abby, E., Dentro, S.C., Hall, M.W.J. et al. Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth. Nat Genet (2023). https://doi.org/10.1038/s41588-022-01280-z